Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
21.42
-0.44 (-2.01%)
May 1, 2024, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $1.00 billion as of May 1, 2024. Its market cap has increased by 504.45% in one year.
Market Cap
1.00B
Enterprise Value
934.13M
1-Year Change
504.45%
Ranking
Category
Stock Price
$21.42
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $509.40M to $1.00B, an increase of 96.62%. That is a compound annual growth rate of 20.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 866.00M | -0.09% |
Apr 29, 2024 | 866.80M | 1.27% |
Apr 26, 2024 | 855.90M | -0.07% |
Apr 25, 2024 | 856.50M | -2.91% |
Apr 24, 2024 | 882.20M | -1.07% |
Apr 23, 2024 | 891.70M | 0.04% |
Apr 22, 2024 | 891.30M | -0.62% |
Apr 19, 2024 | 896.90M | 2.82% |
Apr 18, 2024 | 872.30M | 2.13% |
Apr 17, 2024 | 854.10M | 1.46% |
Apr 16, 2024 | 841.80M | 2.85% |
Apr 15, 2024 | 818.50M | -6.81% |
Apr 12, 2024 | 878.30M | -0.85% |
Apr 11, 2024 | 885.80M | 5.72% |
Apr 10, 2024 | 837.90M | 0.72% |
Apr 9, 2024 | 831.90M | -1.92% |
Apr 8, 2024 | 848.20M | 1.23% |
Apr 5, 2024 | 837.90M | -1.26% |
Apr 4, 2024 | 848.60M | 0.47% |
Apr 3, 2024 | 844.60M | 0.38% |
Apr 2, 2024 | 841.40M | -2.13% |
Apr 1, 2024 | 859.70M | 0.47% |
Mar 28, 2024 | 855.70M | -1.01% |
Mar 27, 2024 | 864.40M | 1.06% |
Mar 26, 2024 | 855.30M | -1.24% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vir Biotechnology | 1.14B |
AtriCure | 1.13B |
AbCellera Biologics | 1.12B |
Maravai LifeSciences Holdings | 1.04B |
Immatics | 1.03B |
Arcutis Biotherapeutics | 1.01B |
Innoviva | 982.55M |
Abivax | 976.48M |